Tegretol CR 400 mg

Tegretol CR 400 mg is an extended-release tablet containing carbamazepine, used for managing certain types of seizures and nerve pain. This medication is designed for oral administration and is manufactured by Novartis Pharmaceuticals Canada Inc.

Tegretol CR 400 mg is primarily used to control specific types of seizures in epilepsy. It may also be prescribed for nerve pain conditions. Carbamazepine, the active ingredient, works by stabilizing electrical activity in the brain. This medication is often considered when other treatments have not been effective.

Common effects of Tegretol CR 400 mg may include dizziness, drowsiness, and nausea. Some users might experience blurred vision or coordination issues. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

Tegretol CR 400 mg should be handled with care, especially for those with a history of liver or kidney problems. It is important to follow the prescribed dosage and not to abruptly stop taking the medication without consulting a healthcare provider. Regular monitoring may be required to ensure safety and effectiveness.

Tegretol CR 400 mg can interact with various medications, including other antiepileptic drugs, antidepressants, and certain antibiotics. Alcohol and other central nervous system depressants may also interact with carbamazepine. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.